FDA Person
FDAKent A. Conforti
View detailed information about Kent A. Conforti, including compliance records, violations, and related data.
Person Profile
FDA investigator. Took part in 110 inspections of 102 companies, 2016–2026.
Inspections (110)
| Date | Company | Classification | Project area | Inspection |
|---|---|---|---|---|
| September 21, 2026 | Biogen, Inc. | Not classified | #1340116 | |
| August 20, 2026 | Alexis M. Cahalane, M.D. | Not classified | #1334006 | |
| July 31, 2026 | Vertex Pharmaceuticals Incorporated | Not classified | #1333028 | |
| July 10, 2026 | Praxis Precision Medicines, Inc. | Not classified | #1332596 | |
| June 24, 2026 | Jeremy Schmahmann, M.D. | Not classified | #1324468 | |
| May 29, 2026 | Biomedical Research Models, Inc. d/b/a Biomere | Not classified | Human Cellular, Tissue, and Gene Therapies | #1319406 |
| April 30, 2026 | Giuseppe Plazzi, M.D. | Not classified | #1317562 | |
| April 10, 2026 | Takeda Pharmaceuticals USA | Not classified | #1313228 | |
| March 19, 2026 | Peter R. Movilla, MD | Not classified | Product Evaluation: Medical Devices | #1308722 |
| March 6, 2026 | Marek Smilowski | NAI | Bioresearch Monitoring | #1309212 |
| February 13, 2026 | Moderna TX Clinical Biomarker Laboratory | Not classified | #1308088 | |
| January 14, 2026 | Nuvalent, Inc. | Not classified | #1300422 | |
| December 19, 2025 | Daniel J. DeAngelo, MD | Not classified | #1297612 | |
| November 17, 2025 | Health Policy Associates, Inc | Not classified | #1292882 | |
| October 21, 2025 | Filipa Lynce, M.D. | VAI | Bioresearch Monitoring: Human Drugs | #1287944 |
| October 21, 2025 | Filipa Lynce, M.D. | VAI | Bioresearch Monitoring | #1287944 |
| September 26, 2025 | University of Vermont & State Agricultural College IRB | Not classified | #1284600 | |
| September 11, 2025 | Boehringer Ingelheim Pharmaceuticals, Inc. | VAI | Bioresearch Monitoring: Human Drugs | #1281125 |
| August 8, 2025 | Amer M. Zeidan, M.D. | VAI | Bioresearch Monitoring: Human Drugs | #1278299 |
| July 18, 2025 | Amir T. Fathi, M.D. | NAI | Bioresearch Monitoring | #1277066 |
Documents (45)
- EIR · Servier Pharmaceuticals, LLC. · March 24, 2022
- EIR · Charles Stephen Foster, M.D. · May 21, 2018
- EIR · Karen D. Wright, M.D. · October 18, 2021
- 483 · Filipa Lynce, M.D. · October 21, 2025
- 483 · Pfizer Inc. · September 22, 2017
- 483 · Mass General Brigham Inc. IRB · May 23, 2017
- 483 · Inci B. Yildirim, M.D. · April 15, 2022
- EIR · Sarepta Therapeutics, Inc. · April 12, 2018
- EIR · Covis Pharma GmBH · October 22, 2018
- 483 · Francine M. Foss · February 3, 2023
- 483 · Aldeyra Therapeutics, Inc. · April 28, 2023
- 483 · Alexion Pharmaceuticals, Inc. · November 7, 2024
- 483 · Filipa Lynce, M.D. · October 21, 2025
- 483 · Sait Ashina, M.D. · April 8, 2025
- 483 · Amer M. Zeidan, M.D. · August 8, 2025
- 483 · Bertrand P. Cole, D.O. · May 16, 2025
- 483 · Labcorp Bedford LLC. · January 24, 2019
- 483 · GE Healthcare Inc. - Life Sciences · March 8, 2024
- 483 · Aditya Bardia, M.D. · February 8, 2021
- 483 · Elizabeth I. Buchbinder, M.D. · October 3, 2022
- 483 · Labcorp Bedford LLC. · September 14, 2021
- 483 · Maria Alora Palli, M.D. · April 29, 2019
- 483 · Maryellen Fitzgerald, M.D. · March 10, 2023
- EIR · Blueprint Medicines Corporation · September 5, 2019
- 483 · Andrew C. Siesennop, MD · August 4, 2023
- 483 · Lumicell, Inc. · August 18, 2023
- 483 · Boehringer Ingelheim Pharmaceuticals, Inc. · September 11, 2025
- 483 · Pfizer, Inc. · June 28, 2017
- EIR · ImmunoGen, Inc. · July 28, 2022
- 483 · Jennifer L. Crombie, M.D. · November 17, 2023
- EIR · Concord Biomedical Science and Emerging Technologies, Inc. · May 23, 2019
- 483 · Concord Biomedical Science and Emerging Technologies, Inc. · May 23, 2019
- EIR · bluebird bio, Inc. · May 6, 2022
- 483 · Nezabravka Petrova Haytova · December 16, 2022
- 483 · Caron Jacobson, Md · December 16, 2020
- EIR · Pfizer Inc. · June 28, 2017
- 483 · Purdue Pharma L.P. · March 29, 2019
- 483 · Wayne G. Shreffler, M.D. · January 31, 2020
- 483 · Resilience US, Inc. · October 10, 2008
- 483 · Dr. A. Sharda · April 7, 2016
- EIR · Pfizer Inc. · September 22, 2017
- 483 · Kaleido Biosciences, Inc. · March 3, 2021
- 483 · Douglas Terp · June 28, 2021
- 483 · Peter R. Movilla, MD · March 19, 2026
- 483 · Biomedical Research Models, Inc. d/b/a Biomere · May 29, 2026
Frequently inspected with (10)
Person Information
Name
Kent A. Conforti
Title
issuing_officer
Role
COMPANY REP
ID: 8d3d3e82-cd97-420e-8840-df92d6eeba09
Get More Insights
Access our comprehensive quality intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
1.5M+ regulatory data points
Real-time compliance monitoring
Interactive analytics dashboard
Looking for more people? Our platform provides access to thousands of FDA people with advanced search and filtering capabilities.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.